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Antioxidants are substances capable of inhibiting oxidation. In chronic diseases, inflam-
matory response cells produce oxygen free radicals. Oxygen free radicals cause DNA
damage, and this may lead to gene modifications that might be carcinogenic. Chronic
Helicobacter pylori infection causes the production of DNA-damaging free radicals. In
recent years, various groups have studied the effects of antioxidants, especially on H.
pylori-associated gastric cancer. In most of the studies, it has been shown that H. pylori
infection does affect the level of antioxidants measured in the gastric juice, but there are
also controversial results. Recent experimental studies, both in vivo and in vitro, have
shown that vitamin C and astaxanthin, a carotenoid, are not only free radical scavengers
but also show antimicrobial activity against H. pylori. It has been shown that astaxanthin
changes the immune response to H. pylori by shifting the Th1 response towards a Th2 T-
cell response. Very few experimental studies support the epidemiologic studies, and
further studies are needed to describe the effect and the mechanism of antioxidants in the
H. pylori immune response.
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Antioxidants, due to their important role in
chronic processes such as cardiovascular diseases,
cancer, inflammatory bowel disease and Alzhei-
mer’s disease, as shown by many multidisciplin-
ary research groups, have become an important
research topic [1–3]. Antioxidants are substances
capable of inhibiting oxidation that can easily give
away an oxygen molecule without requiring
much energy. An ideal antioxidant should be
stable and should be effective over a wide pH
range. Oxidation is the addition of oxygen or
the removal of hydrogen. The chain reaction of
oxidation requires a minimum amount of oxygen.
An antioxidant can stop the chain reaction by
giving away an electron without changing its sta-
bility [4,5]. Fruit and vegetables are the main
source of antioxidant nutrients, especially vitamin
C, vitamin E and carotenoids [6].
In chronic diseases such as H. pylori infection,
the active inflammatory response is induced
with neutrophilic infiltration. These neutrophils,
macrophages and/or monocytes produce oxygen
free radicals that can cause DNA damage to the
adjacent cells. The DNA damage provoked by
oxygen free radicals could have very harmful
consequences, leading to gene modifications that
are potentially carcinogenic [7]. Free radicals play
an important role in the pathogenesis of gastro-
duodenal mucosal inflammation, peptic ulcer dis-
ease, and probably, even gastric cancer [8]. Factors
that are suspected to influence the progression of
this chain of events are: infection with H. pylori, a
major cause of chronic gastritis; excessive salt
intake, which is known to induce atrophy in
experimental animals; increased cell replication,
which potentiates the effect of gastric carcinogens;
and carcinogens acting on the gastric epithelium,
such as N-nitroso compounds and free oxygen
radicals [3]. Infection with H. pylori causes gastri-
tis, and with excessive salt intake, atrophy evolves,
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which is the first stage of carcinogenesis. Antiox-
idants have the potential to neutralize DNA-dama-
ging free radicals, which are generated by various
factors, such as chronic H. pylori infection, and
might therefore lower the risk of gastric cancer
[9]. Most of the antioxidant studies, performed
with vitamin C (ascorbic acid), reveal that H.
pylori-infected patients have lower gastric ascorbic
acid levels. Ascorbic acid might act to reduce the
risk of gastric cancer in two ways: (1) it is a good
nitrite scavenger and could thereby reduce the
endogenous formation of carcinogenic N-nitroso
compounds in the stomach lumen by its presence
in gastric juice; and (2) high mucosal concentra-
tions of ascorbic acid may be important in limiting
free radical-mediated damage within the epithe-
lium, such as H. pylori-associated gastritis [10].
After the oral intake of vitamin C, the reduced
form of ascorbic acid (AA) is oxidized to dehy-
droascorbic acid (DHAA). DHAA is absorbed in
the small intestine and then reduced again by
blood cells to AA. From the blood, it is secreted
into the stomach and excreted in the urine. In the
stomach at a pH above 3, AA is oxidized to DHAA
[11]. In subjects with H. pylori infection, AA
becomes impaired, the vitamin C concentrations
in gastric juice become subnormal, and a signifi-
cant proportion is found to be the inactive oxidized
form of DHAA [12–14] (Figure 1).
Most of the human studies related to gastric
cancer show that the cancer risk is reduced by
ascorbic acid intake in a dose-dependent way [15].
In H. pylori-infected patients, the ascorbic acid
levels are lower than in the normal population
[14,16,17], but in some studies there was no change
in ascorbic acid levels according to their H. pylori
status [18]. These controversial findings could
be due to the methods employed for measuring
the ascorbic acid or vitamin C levels in different
studies. Gastric juice vitamin C levels are asso-
ciated closely with gastric pathology, but there is
no association with plasma levels [12]. H. pylori
infection has been associated with reduced levels
of both vitamin C and ascorbic acid in the gastric
juice but not in the plasma [14]. Lipid-soluble
antioxidants, like vitamin E, either have no
obvious role in protecting mucosal cells from free
radical damage or they do indeed have scavenging
potential against free radicals. However, they can
be rapidly converted back to their original form by
redox or other processes [19]. In a study by Zhang
et al. it was shown that vitamin C is not only an
antioxidant and a free radical scavenger, but it also
shows antimicrobial activity both in vitro and in
vivo. The minimal inhibitory concentration values
of vitamin C for 64 H. pylori strains were tested by
the agar dilution method, and vitamin C showed
an inhibitory effect dependent on pH, whereas
vitamin E showed no effect on H. pylori growth.
The in vivo experiment performed on Mongolian
gerbils suggested that a high dose of vitamin C had
an inhibitory effect on H. pylori colonization in the
gerbils’ stomachs [20]. In the study performed by
Wang et al. the effects on H. pylori infection of the
lipid-soluble antioxidant astaxanthin, which is a
carotenoid, found in seafood, especially salmon,
and a water-soluble antioxidant, vitamin C, were
tested both in vivo and in vitro. Mice treated with
astaxanthin-rich meals or vitamin C showed sig-
nificantly lower colonization levels and lower
inflammation scores than those that were
untreated. Lipid peroxidation was also signifi-
cantly decreased compared to the untreated
group. Both astaxanthin and vitamin C showed
an inhibitory effect on the in vitro growth of H.
pylori [21].
The pathogenesis of H. pylori infection is partly
due to the immunologic response. The infiltration
of neutrophils results in free radicals, which initi-
ate a membrane peroxidation cascade that leads to
mucosal damage, disrupting the integrity of the
biological membranes. The immune response is
polarized to a Th1 cell-mediated response with
release of interferon gamma (IFN-g), which acti-
vates phagocytic cells and contributes to mucosal
damage [22,23]. In the study by Bennedsen et al.
the effect of antioxidants on the immune response
to H. pylori was evaluated. It was shown that mice
treated with astaxanthin showed a significantFigure 1 The route of ascorbic acid, after oral intake.
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increase in interleukin-4 release, which indicates a
shift towards a Th2 T-cell response. The observed
shift of the Th1/Th2 balance following treatment
was probably the result of the downregulation of
Th1 cells and upregulation of Th2 cells by the
antioxidant astaxanthin; another possible mechan-
ism of action is that it neutralizes reactive free
oxygen metabolites in the mucosa [24]. The pre-
liminary chemotaxis and oxidative burst results of
investigations on astaxanthin, algamel (a powder
from a plant that contains astaxanthin naturally),
vitamin E and dimethylsulfoxide in H. pylori show
that the compounds tested had no effect on che-
motaxis. However, astaxanthin and algamel had a
negative effect on oxidative burst, which supports
the findings of the epidemiologic studies (L. P.
Andersen, personal communication).
Further studies are needed to describe the effect
and the mechanism of antioxidants in the H. pylori
immune response. Antioxidants may not repre-
sent the only answer for the treatment of H. pylori
infection, but the studies do show that they might
constitute a supportive treatment.
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